| 000 | 01840 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514021940.0 | ||
| 264 | 0 | _c20020125 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0270-9139 | ||
| 024 | 7 |
_a10.1053/jhep.2002.30319 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSulkowski, Mark S | |
| 245 | 0 | 0 |
_aHepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. _h[electronic resource] |
| 260 |
_bHepatology (Baltimore, Md.) _cJan 2002 |
||
| 300 |
_a182-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 | _aAlkynes |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xadverse effects |
| 650 | 0 | 4 |
_aAntiretroviral Therapy, Highly Active _xadverse effects |
| 650 | 0 | 4 |
_aAspartate Aminotransferases _xblood |
| 650 | 0 | 4 | _aBenzoxazines |
| 650 | 0 | 4 |
_aBilirubin _xblood |
| 650 | 0 | 4 | _aChemical and Drug Induced Liver Injury |
| 650 | 0 | 4 | _aCyclopropanes |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis B _xcomplications |
| 650 | 0 | 4 |
_aHepatitis C _xcomplications |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Diseases _xdiagnosis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNevirapine _xadverse effects |
| 650 | 0 | 4 |
_aOxazines _xadverse effects |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xadverse effects |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aThomas, David L | |
| 700 | 1 | _aMehta, Shruti H | |
| 700 | 1 | _aChaisson, Richard E | |
| 700 | 1 | _aMoore, Richard D | |
| 773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 35 _gno. 1 _gp. 182-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1053/jhep.2002.30319 _zAvailable from publisher's website |
| 999 |
_c11698392 _d11698392 |
||